Pena Luis C. 4
4 · Evommune, Inc. · Filed Nov 12, 2025
Insider Transaction Report
Form 4
Evommune, Inc.EVMN
Pena Luis C.
DirectorPresident & CEO
Transactions
- Conversion
Common Stock
2025-11-07+24,225→ 682,821 total - Conversion
Series Seed Preferred Stock
2025-11-07−206,355→ 0 total→ Common Stock (24,225 underlying)
Footnotes (1)
- [F1]Each share of Series Seed Preferred Stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering for no additional consideration on a 1-for-8.518 basis and had no expiration date.